Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017160 (
gastroenteritis
)
11,398
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Thermotolerant
Campylobacter
species
C. jejuni
and
C. coli
are actually recognized as the major bacterial agent responsible for food-transmitted
gastroenteritis
. The most effective antimicrobials against
Campylobacter
are macrolides and some, but not all aminoglycosides. Among these, susceptibility to streptomycin is reduced by mutations in the ribosomal RPSL protein or by expression of
ANT
(6)-I aminoglycoside O-nucleotidyltransferases. The presence of streptomycin resistance genes was evaluated among streptomycin-resistant
Campylobacter
isolated from humans and animals by using PCR with degenerated primers devised to distinguish
ant(6)-Ia
,
ant(6)-Ib
and other
ant
-like genes. Genes encoding
ANT
(6)-I enzymes were found in all possible combinations with a major fraction of the isolates carrying a previously described
ant
-like gene, distantly related and belonging to the new
ant(6)-I
sub-family
ant(6)-Ie
. Among
Campylobacter
isolates,
ant(6)-Ie
was uniquely found functional in
C. coli
, as shown by gene transfer and phenotype expression in
Escherichia coli
, unlike detected coding sequences in
C. jejuni
that were truncated by an internal frame shift associated to RPSL mutations in streptomycin resistant strains. The genetic relationships of
C. coli
isolates with
ANT
(6)-Ie revealed one cluster of strains presented in bovine and humans, suggesting a circulation pathway of
Campylobacter
strains by consuming contaminated calf meat by bacteria expressing this streptomycin resistance element.
...
PMID:
ant(6)-I
Genes Encoding Aminoglycoside O-Nucleotidyltransferases Are Widely Spread Among Streptomycin Resistant Strains of
Campylobacter jejuni
and
Campylobacter coli
. 3040 73